<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR20">
 <label>20.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Verelst</surname>
    <given-names>SG</given-names>
   </name>
   <name>
    <surname>Termorshuizen</surname>
    <given-names>F</given-names>
   </name>
   <name>
    <surname>Uyl-de Groot</surname>
    <given-names>CA</given-names>
   </name>
   <name>
    <surname>Schaafsma</surname>
    <given-names>MR</given-names>
   </name>
   <name>
    <surname>Ammerlaan</surname>
    <given-names>AH</given-names>
   </name>
   <name>
    <surname>Wittebol</surname>
    <given-names>S</given-names>
   </name>
   <name>
    <surname>Sinnige</surname>
    <given-names>HA</given-names>
   </name>
   <name>
    <surname>Zweegman</surname>
    <given-names>S</given-names>
   </name>
   <name>
    <surname>van Marwijk</surname>
    <given-names>KM</given-names>
   </name>
   <name>
    <surname>van der Griend</surname>
    <given-names>R</given-names>
   </name>
   <name>
    <surname>Lokhorst</surname>
    <given-names>HM</given-names>
   </name>
   <name>
    <surname>Sonneveld</surname>
    <given-names>P</given-names>
   </name>
   <name>
    <surname>Wijermans</surname>
    <given-names>PW</given-names>
   </name>
   <collab>Dutch-Belgium Hemato-Oncology Cooperative G</collab>
  </person-group>
  <article-title>Effect of thalidomide with melphalan and prednisone on health-related quality of life (HRQoL) in elderly patients with newly diagnosed multiple myeloma: a prospective analysis in a randomized trial</article-title>
  <source>Ann Hematol</source>
  <year>2011</year>
  <volume>90</volume>
  <issue>12</issue>
  <fpage>1427</fpage>
  <lpage>1439</lpage>
  <pub-id pub-id-type="doi">10.1007/s00277-011-1224-1</pub-id>
  <?supplied-pmid 21472373?>
  <pub-id pub-id-type="pmid">21472373</pub-id>
 </element-citation>
</ref>
